|
WHO Model List of Essential Medicines (2021)
|
6.4.2.5 Fixed-dose combinations of antiretroviral medicines
|
No observations
|
|
PAHO Strategic Fund Medicine List
|
2.6.1. Antiretrovirals
|
No observations
|
|
Peru
|
6.4.2.3 Protease Inhibitors
|
No observations
|
|
Ecuador
|
Essential Medicines List - Ecuador
|
No observations
|
|
Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015
|
07.07 ANTIVIRALS
|
No observations
|
|
Mexico. Cuadro Basico de Medicamentos - 2017
|
06. ENFERMEDADES INFECCIOSAS Y PARASITARIAS
|
No observations
|
|
Brasil. Relação Nacional de Medicamentos Essenciais. 2020
|
J. ANTI-INFECCIOSOS PARA USO SISTEMICO
|
No observations
|
|
Paraguay. Lista de Medicamentos Esenciales. 2009
|
05. ANTIVIRALES DE USO SISTÉMICO
|
No observations
|
|
El Salvador - 2019
|
ANTIVIRALES DE USO SISTÉMICO
|
No observations
|
|
Chile. Formulario Nacional de Medicamentos. 2005
|
06.05. ANTIVIRALES
|
No observations
|
|
Guyana. Essential Medicines List. 2020-2021
|
7.09.02.01. Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
|
No observations
|
|
Organisation of Eastern Caribbean States. Medical Products List. 2019-2021
|
8:18 Antiretroviral Agents
|
No observations
|
|
Suriname. NGK-C-011
|
6.12 Antiretrovirals
|
No observations
|
|
Suriname. NGK-C-011
|
29.1 Antiretrovirals
|
No observations
|
|
Haiti. National List of Essential Medicines
|
06.04.02.05 Fixed Doses
|
No observations
|
|
Barbados. Barbados National Drug Formulary (BNDF)
|
08.18.08.20 Nucleoside Reverse Transcriptase Inhibitors
|
No observations
|
|
Bahamas. Drug Formulary
|
07.03.01. Anti-Retroviral (ARV) Agents
|
No observations
|
|
Belize. National Drug Formulary
|
06.04.02.01 Nucleoside reverse transcriptase inhibitors
|
No observations
|
